Saving Lives of Cancer Patients by Addressing Cancer-Associated Thrombosis

The European Thrombosis and Haemostasis Alliance (ETHA) welcomes the proposed EU research mission on cancer and firmly believes that to reduce death and disability from cancer across Europe, cancer-associated thrombosis must become ...
Header image

The European Thrombosis and Haemostasis Alliance (ETHA) is an international alliance based in Brussels, Belgium, with 24 member organisations in the field of thrombosis and hemostasis in member states of the European Union (EU) and in the U.S.

The mission of ETHA is to give the thrombosis and hemostasis community a voice and drive prioritisation of thrombosis and hemostasis in the EU patient safety and research programs. With a united focus on raising awareness of bleeding and clotting disorders, ETHA stands together to work with the public as well as decision makers’ to provide input into EU health and patient safety strategies.

To learn more about ETHA’s initial area of priority, read the consensus statement, here.

News

ETHA Statement for Universal Health Coverage Day on 12 Decem...

Universal Health Coverage Day is on 12 December. To recognize and help support this important day, the European Thrombosis and Haemostasis Alliance (ETHA), is sharing the following joint statement: 1 in 4 people worldwide are dying ...

Continue reading

Cancer-Associated Thrombosis Roundtable Brings Together MEPs...

On 16 October, the European Thrombosis and Haemostasis Alliance (ETHA) held the Roundtable Discussion on Cancer-Associated Thrombosis (CAT) and the EU Cancer Agenda Event hosted by MEP Juozas Olekas in recognition of World Thrombosi...

Continue reading